Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c00705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Rosa De Gregorio und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Naples "Federico II", Via D. Montesano, 49, I-80131 Naples, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Receptors, G-Protein-Coupled, Leukemia Inhibitory Factor Receptor alpha Subunit. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
Fibrosis is a pathological process characterized by excessive deposition of the extracellular matrix (ECM) within tissues. Chronic fibrotic disorders involving the lungs, liver, intestine, and kidneys represent a major cause of morbidity and mortality and remain a major unmet therapeutic need. In the liver, the development of pathological ECM depends on the activation of key cell targets, i.e., the hepatic stellate cells (HSC). HSCs express the leukemia inhibitory factor receptor (LIFR), which promotes fibrosis, and a bile acid-activated receptor, GPBAR1, which attenuates HSC activation. Herein, we report the design and synthesis of a new class of 4,9-estradien-3,17-dione derivatives acting as dual LIFR inhibitors and GPBAR1 agonists. In silico and pharmacological characterization of these dual modulators led to the identification of compound 2o as a first-in-class LIFR/GPBAR1 modulator that reverses liver fibrosis in vitro and in vivo. These findings demonstrate the therapeutic potential of LIFR/GPBAR1 hybrid molecules in human fibrotic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano, 49, I-80131 Naples, Italy.
- Department of Medicine and Surgery, University of Perugia, Piazza L. Severi 1, 06132 Perugia, Italy.
ORCID-Profile: Federica Moraca, Bianca Fiorillo, Bruno Catalanotti, Valentina Sepe, Angela Zampella
Förderung
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
De Gregorio, R., Moraca, F., Rapacciuolo, P., Fiorillo, B., Morretta, E., Di Giorgio, C., Marchianò, S., Lachi, G., Massa, C., Sensini, B., Biagioli, M., Spinelli, L., Monti, M. C., Catalanotti, B., Sepe, V., Fiorucci, S., & Zampella, A. (2025). Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00705
Vancouver
De Gregorio R, Moraca F, Rapacciuolo P, Fiorillo B, Morretta E, Di Giorgio C, et al. Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00705
BibTeX
@article{DeGregorio2025,
author = {De Gregorio, Rosa and Moraca, Federica and Rapacciuolo, Pasquale and Fiorillo, Bianca and Morretta, Elva and Di Giorgio, Cristina and Marchianò, Silvia and Lachi, Ginevra and Massa, Carmen and Sensini, Benedetta and Biagioli, Michele and Spinelli, Lucio and Monti, Maria Chiara and Catalanotti, Bruno and Sepe, Valentina and Fiorucci, Stefano and Zampella, Angela},
title = {Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c00705}
}
EUVIMED